Effective treatment strategy in elderly breast cancer patients;Idoskori emlodaganatok kezelésének lehetoségei

Orvosi Hetilap

Volumn 146, Issue 1, 2005, Pages 15-21

  Boér, Katalin ^a,b  

^a Szent Margit Kórház Szülészeti és Nögyógyászati Osztály   (Hungary)

^b NONE   (Hungary)

Author keywords

Chemotherapy; Elderly breast cancer; Endocrine therapy; Radiotherapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; HORMONE; METHOTREXATE; PROGESTERONE RECEPTOR; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

AGED; AGING; ANAMNESIS; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COMORBIDITY; CONTROLLED STUDY; DRUG MECHANISM; ELDERLY CARE; ENVIRONMENTAL FACTOR; FEMALE; HEALTH STATUS; HORMONAL THERAPY; HUMAN; INTRAOPERATIVE RADIOTHERAPY; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL LITERATURE; METASTASIS; MORBIDITY; PATIENT COMPLIANCE; PATIENT SAFETY; PATIENT SELECTION; PROGNOSIS; SELF CONCEPT; SENTINEL LYMPH NODE; SURGICAL MORTALITY; TREATMENT PLANNING; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AXILLA; BODY IMAGE; BREAST TUMOR; DRUG INTERACTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; METHODOLOGY; PATHOLOGY; POLYPHARMACY; QUALITY OF LIFE; REVIEW;

ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AXILLA; BODY IMAGE; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DRUG INTERACTIONS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY; POLYPHARMACY; PROGNOSIS; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT;

EID: 14544286419     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Aapro, M.. Extermann, M., Repetto, L.: Evaluation of the elderly with cancer. Ann. Oncol., 2000, 11 (Suppl 3), 223-229.
2. Balducci, L., Beghe, C.: Cancer and age in the USA. Crit. Rev. Oncol. Hematol., 2001, 37, 137-145.
3. Balducci, L., Yates, J.: General guidelines for management of older patients with cancer. Oncology, 2000, 14, 221-227.
4. Bernstein, V., Thurlimann, B., Robertson, J. F. és mtsai: Breast cancer biology, treatment and survival in elderly women. Proc. Am. Soc. Clin. Oncol., 2001, 20, 247a, Abstract 985.
5. Carlson, R. W.: Sequencing of endocrine terapies in breast cancer-integration of recent data. Breast Cancer Res. Treat., 2002, 75 (Suppl. 1., 27-32.
6. Castiglione, M., Gelber, R. D., Goldhirsch, A.: Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group. J. Clin. Oncol., 1990, 8, 519-526.
7. Cooke, A. L., Perera, F., Fisher, B. és mtsai: Tamoxifen with and without radiation after partial mastectomy in patients involved nodes. Int. J. Radiat. Oncol. Biol. Phys., 1995, 31, 777-781.
8. Coombes, Ch., Hall, E., Gibson, L. és mtsai: A randomized trial of exemestane after two years of tamoxifen therapy in postmenopausal women with primary breast cancer., N. Engl. J. Med., 2004, 350, 1081-1092.
9. de Winter, K., van den Weyngaert, D., Becquart, D. és mtsai: Breast cancer: influence of age on treatment choice of surgeon and radiation oncologist. Eur. J. Cancer, 1993, 29A, S73.
10. Diab, S. G., Elledge, R. M., Clark, G. M.: Tumor characteristics and clinical outcome of elderly women with breast cancer. J. Natl. Cancer Inst., 2000, 92, 550-556.
11. Dixon, J. M., Love, C. D. B., Bellamy, C. és mtsai: Letrozole as primary medical therapy for locally advanced and large operable breast cancer. Breast Cancer Res. Treat., 2001, 66, 1919-1929.
12. Dixon, J. M., Renshaw, L., Bellamy, C. és mtsai: The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study. Clin. Cancer Res., 2000, 6, 2229-2235.
13. Durnas, C., Loi, C., Cusack, B. J.: Hepatic drug metabolism and aging. Clin. Pharmacokinetic., 1990, 17, 236-245.
14. Early Breast Cancer Trialists' Collaborative Group: Polychemotherapy for early breast cancer: an overview of the randomized trials. Lancet, 1998, 352, 930-942.
15. Eckhardt S.: Az emlorák endokrin kezelésének kutatási távlatai. Magyar Onkológia, 2003, 47, 133-140.
16. Ellis, M. J., Coop, A., Singh, B. és mtsai: Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor- positive primary breast cancer: evidence from a phase III randomized trial. J. Clin. Oncol., 2001, 19, 3808-3816.
17. Fisher, B., Anderson, S., Bryant, J. és mtsai: Twenty-year follow-up of a randomized trial compared total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N. Engl. J. Med., 2002, 347, 1233-1241.
18. Goldhirsch, A., Wood, W. C., Gelber, R. D. és mtsai: Meeting highlights: Updated international expert consensus on the primary therapy of early breast cancer. J. Clin. Oncol., 2003, 21, 3357-3365.
19. Goss, P., Ingle, N., Martino, S. és mtsai: A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N. Engl. J. Med., 2003, 349, 1793-1802.
20. Hainsworth, J., Burris, H., Yardley, D. és mtsai: Weekly docetaxel in the Treatment of Elderly Patients with Advanced Breast Cancer: A Minnie Pearl Cancer Research Network Phase II Trial. J. Clin. Oncol., 2001, 19, 3500-3505.
21. Hughes, K. S., Schnaper, L., Berry, D. és mtsai: Comparison of lumpectomy plus tamoxifen with and without radiotherapy (RT) in women 70 years of age or older who have clinical stage I, estrogen receptor positive (ER+) breast carcinoma. Proc. Am. Soc. Clin. Oncol., 2001, 20, Abstract 93.
22. Ibrahim, N. K., Buzdar, A. U., Asmar, L. és mtsai: Doxorubicin based adjuvant chemotherapy in elderly breast cancer patients: the M.D. Anderson experience, with long-term follow-up. Ann. Oncol., 2000, 11, 1597-1601.
23. Kemeny, M. M., Busch-Devereaux, E., Merriam, L. T. és mtsai: Cancer surgery in the elderly. Hematol. Oncol. Clin. North. Am., 2000, 14, 169-192.
24. Kimmi, G. G., Balducci, L.: Breast cancer and aging. Clinical interactions. Hematol. Oncol. Clin. North. Am., 2000, 14, 213-234.
25. Monfardini, S., Sorio, R., Hoctin Boes, G.: Entry and evaluation of elderly patients in European Organization for Research and Treatment of Cancer (EORTC) new drug development studies. Cancer, 1995, 76, 333-338.
26. Mouridsen, H., Gershanocich, M., Sun, Y. és mtsai: phase III. study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group. J. Clin. Oncol., 2003, 21, 2101-2109.
27. Nabholtz, J. M., Bonneterre, J., Buzdar, A. és mtsai: Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results. Eur. J. Cancer, 2003, 39, 1684-1689.
28. Piccart, M.: New stars in the sky of treatment for early breast cancer. N. Engl. J. Med., 2004, 11, 350, 1140-1142.
29. Pignon, T., Scalliet, P.: Radiotherapy in the elderly. Eur. J. Surg. Oncol., 1998, 24, 407-411.
30. Safra, T., Muggia, F., Jeffers, S. és mtsai: Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2 Ann. Oncol., 2000, 11, 1029-1033.
31. Steger, G., Bartsch, R., Wenzel, C. és mtsai: Fulvestrant (Faslodex) in metastatic breast cancer. Breast Cancer Res. Treat., 2003, 82 (Suppl. 1.), 104-107.
32. Sandison, A. J., Gold, D. M., Wright, P. és mtsai: Breast conservation or mastectomy: treatment choice of women aged 70 years and older. Br. J. Surg., 1996, 83, 994-997.
33. Svastics, E., Sulyok, Z., Besznyák, I.: Treatment of breast cancer in women older than 70 years. J. Surg. Oncol., 1989, 41, 19-23.
34. The ATAC Trialists Group: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial efficacy and safety update analyses. Cancer, 2003, 98, 1802-1810.
35. Thomas, A. G., Jemal, A., Thun, M. J.: Breast cancer facts and figures. American Cancer Society. Inc. Atlanta., 2001, 1-19. old.
36. Tije ten, A. J., Smorenburg, C. H., Seynaeve, C. és mtsai: Weekly paclitaxel as first line chemotherapy for elderly patients with metastatic breast cancer. A multicentre phase II trial. Eur. J. Cancer., 2004, 40, 352-357.
37. Veronesi, U., Luini, A., Del Vecchio, M. és mtsai: Radiotherapy after breast preserving surgery in women with localized cancer of the breast. N. Engl. J. Med., 1993, 328, 1587-1591.
38. Veronesi, U., Orecchia, R., Luini, A. és mtsai: A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur. J. Cancer, 2001, 37, 2178-2183.
39. Walter, L. C., Covinsky, K. E.: Cancer screening in elderly patients: A framework for individualized decision making. JAMA, 2001, 285, 2750-2756.
40. Wazer, D. E., Erban, J. K., Robert, N. J. és mtsai: Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection. Cancer, 1994, 74, 848-853.
41. Yancik, R., Ries, L. A.: Aging and cancer in America. Demographic and epidemiologic perspectives. Hematol. Oncol. Clin. North. Am., 2000, 14, 17-24.